Cart
sales@molnova.com
Calcium glycerophosphate
CAS No. 27214-00-2
Calcium glycerophosphate( —— )
Catalog No. M35393 CAS No. 27214-00-2
Calcium glycerophosphate(CaGP) is an inhibitor of intestinal alkaline phosphatase F3. Calcium glycerophosphate can be a source of calcium and phosphorus in total parenteral nutrition solutions .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 26 | Get Quote |
|
Biological Information
-
Product NameCalcium glycerophosphate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalcium glycerophosphate(CaGP) is an inhibitor of intestinal alkaline phosphatase F3. Calcium glycerophosphate can be a source of calcium and phosphorus in total parenteral nutrition solutions .
-
DescriptionCalcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3. Calcium glycerophosphate is a source of calcium and phosphorus in total parenteral nutrition solutions.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPhosphorylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27214-00-2
-
Formula Weight210.14
-
Molecular FormulaC3H7CaO6P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : < 0.1 mg/mL (insoluble)DMSO : < 1 mg/mL (insoluble or slightly soluble)
-
SMILESO=P([O-])([O-])OCC(O)CO.[Ca+2]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Datta P, et al. Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport. World J Gastroenterol. 2015;21(30):9055-9066. ?
molnova catalog
related products
-
Naloxone HCl Dihydra...
Naloxone HCl Dihydrate is an opioid inverse agonist drug used to counter the effects of opiate overdose.
-
Mefloquine
Mefloquine, a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor.
-
A2ti-1
A2ti-1 is a highly selective inhibitor of annexin A2/S100A10 heterotetramer (A2t) (IC50: 24 μM) that inhibits ARV-mediated activation of Src and p38 mitogen-activated protein kinase (MAPK).
